Objective Endometrial cancer (EC) is one of the most common gynecologic malignancies.
The present study aims to identify a metabolism-related biosignature for EC and explore the …

Background Metabolism dysfunction can affect the biological behavior of tumor cells and
result in carcinogenesis and the development of various cancers. However, few thoughtful …

Background Metabolic abnormalities have recently been widely studied in various cancer
types. This study aims to explore the expression profiles of metabolism-related genes …

Objective Metabolic syndrome (MetS) is closely related to the increased risk and poor
prognosis of endometrial cancer (EC). The purpose of this study was to analyze the …

Background Endometrial cancer was the commonest gynecological malignancy in
developed countries. Despite striking advances in multimodality management, however, for …

Simple Summary Endometrial cancer (EC) mortality is directly associated with the presence
of poor prognostic factors. Molecular prognostic factors have been identified, but none are …

Glucose metabolic reprogramming and immune imbalance play important roles in the
progression of cancers. The purpose of this study is to develop a glycolysis-related …

Background Metabolic reprogramming is one of hallmarks of cancer progression and is of
great importance for the tumor microenvironment (TME). As an abundant metabolite, lactate …

Objective Aimed to construct an immune-related risk signature and nomogram predicting
endometrial cancer (EC) prognosis. Methods An immune-related risk signature in EC was …

Backgrounds Epithelial–mesenchymal transition (EMT) is a sequential process where tumor
cells develop from the epithelial state to the mesenchymal state. EMT contributes to various …